Valérie Calenda
InvestorManaging Partner at Mérieux Equity Partners · Principal at MIG Capital AG
Lyon, Auvergne-Rhône-Alpes, France
Find your path to Valérie
39 people in our graph share verified history with Valérie — schools, employers, funds. One of them is your warm intro.
About
Valérie Calenda is a Managing Partner at Mérieux Equity Partners, which she joined as Partner in January 2010, focusing on venture deal flow and investments and supporting more than ten companies in Europe and North America. She began her career as a research scientist in hematology and virology at Inserm before joining Transgene S.A., where she managed programs in HIV, cardiovascular disease, and oncology, advanced product candidates to clinical stage, and contributed to license agreements including a 2007 agreement with Hoffmann-La Roche on the HPV cancer vaccine candidate TG4001. She holds a PhD in pharmacology, a degree in hematology, and a B.Sc. in biochemistry-immunology from the University of Marseille, and serves on the boards of companies including Amyl Therapeutics, Keranova, AcuSurgical, Deepull, Biophta, and Prodigest.
Contact· self-published, not guessed
Experience
- Merieux Equity PartnersManaging Partnercurrent2010 — presentLyon, France
Skills & more
From Valérie's professional profile.
Colleagues at Mérieux Equity Partners
Frequently asked questions
- Who is Valérie Calenda?
- Valérie Calenda is a Managing Partner at Mérieux Equity Partners, which she joined as Partner in January 2010, focusing on venture deal flow and investments and supporting more than ten companies in Europe and North America. She began her career as a research scientist in hematology and virology at Inserm before joining Transgene S.A., where she managed programs in HIV, cardiovascular disease, and oncology, advanced product candidates to clinical stage, and contributed to license agreements including a 2007 agreement with Hoffmann-La Roche on the HPV cancer vaccine candidate TG4001. She holds a PhD in pharmacology, a degree in hematology, and a B.Sc. in biochemistry-immunology from the University of Marseille, and serves on the boards of companies including Amyl Therapeutics, Keranova, AcuSurgical, Deepull, Biophta, and Prodigest.
- Where does Valérie Calenda work?
- Valérie Calenda is Managing Partner at Mérieux Equity Partners.
- Where did Valérie Calenda go to school?
- Valérie Calenda studied at Faculté des Sciences de Marseille Luminy, Faculté de Pharmacie de Marseille.